Clinical Trial Update: A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients [Phase 2]

View source ↗

Summary

Phase II trial evaluating XELOX chemotherapy with or without surgery of the primary lesion for metastatic colon cancer, sponsored by Fudan University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Colon Cancer | Phase 2 | Status: UNKNOWN